ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LAB vs NAUT // DIVIDEND YIELD & FCF PAYOUT SAFETY

Standard BioTools Inc. (NASDAQ) VS. Nautilus Biotechnology Inc. (NASDAQ) • 15-METRIC TALLY: LAB 2 — NAUT 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LAB VS. NAUT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LAB NAUT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -28.70% -35.00% +6.30 LAB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -12.99% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -6.20% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 LAB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.8 57.4 -19.66 NAUT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $244.7M $399.9M -$155.3M NAUT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LAB REV NAUT REV LAB GROSS % NAUT GROSS % LAB FCF NAUT FCF
FY 2025 $85.3M $0 49.9% — -$82.6M -$52.0M
FY 2024 $91.0M $0 49.3% — -$151.8M -$61.3M
FY 2023 $106.3M $0 — — -$43.3M -$51.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LAB // BETA —
NAUT // BETA —